Clinical and Translational Epidemiology Branch (CTEB)

The Clinical and Translational Epidemiology Branch (CTEB) focuses on etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions.

CTEB's mission is to plan, develop, direct, coordinate, and evaluate:

  • A comprehensive program of epidemiologic research in human populations related to etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions;
  • A program of epidemiologic research to study differences in cancer susceptibility and risk in individuals and populations and the multiple environmental and genetic factors that jointly contribute to development of cancer among individuals with underlying diseases and conditions and progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions with the ultimate goal of elucidating cancer development and progression among people with these health conditions;
  • A program of extramural epidemiologic research to evaluate the association of and magnitude of cancer risk associated with biomarkers of cancer development and progression in individuals with underlying diseases and cancer; and
  • Resources, infrastructures, and consortia with a focus on cancer development and progression in individuals with underlying diseases and cancer to facilitate and maximize the scientific potential of cancer epidemiology research.

Its mission also is to disseminate findings from the research supported by the Branch to the public, health care professionals, scientists engaged in cancer control, and the public health community.

The populations studied in the grants in CTEB are primarily patient populations - individuals who have had cancer, have premalignant conditions or certain chronic or genetic diseases that may predispose to cancer, or have experienced certain treatments, such as immunosuppression after organ transplants, that may predispose to cancer.


CTEB Staff

Branch Name / Title / Contact Info Interest Areas
CTEB

Freedman, Andrew N., Ph.D.
Branch Chief

Phone: (240) 276-6697
Email: freedmaa@mail.nih.gov

  • Developing, applying, and evaluating prediction models for cancer risk and prognosis
  • Developing benefit/risk indices for pharmaceuticals used to prevent and treat cancer
  • Identifying clinical, epidemiologic, and pharmacogenomic factors related to cancer treatment outcomes
CTEB

Cook, Allison
Extramural Support Specialist

Phone: (240) 276-6687
Email: cookal@mail.nih.gov

  • Social Epigenomics
  • Cancer and the Environment
  • Global Health
  • Risk Communication about Environmental Public Health
  • Long-term Effects of Exposure to Radiation and Toxins
  • Food Security
  • Urban Public Health Systems
CTEB

Durham, Danielle, Ph.D., M.P.H.
Cancer Prevention Fellow

Phone: (240) 276-7076
Email: Danielle.durham@nih.gov

  • Breast Cancer Epidemiology
  • Breast Cancer Screening
  • Health Disparities
  • Health Services Research
  • Cancer Survivorship
  • End-of-Life Care
CTEB

Elena, Joanne, Ph.D., M.P.H.
Program Director

Phone: (240) 276-6818
Email: elenajw@mail.nih.gov

  • Dietary and lifestyle risk factors related to cancer progression, recurrence, and survival outcomes
  • Design and Use of Cohort Studies, particularly for Cancer Survivor Populations
CTEB

Fagan, Sarah, M.P.H.
Cancer Research Training Award Fellow

Phone: (240) 276-7673
Email: sarah.fagan@nih.gov

  • Health Disparities
  • Women’s Health
  • Survivorship
CTEB

Filipski, Kelly K., Ph.D., M.P.H.
Program Director

Phone: (240) 276-6841
Email: filipskikk@mail.nih.gov

  • Pharmacogenomic factors related to cancer treatment outcomes and toxicity
CTEB

Gallicchio, Lisa, Ph.D.
Program Director

Phone: (240) 276-5741
Email: lisa.gallicchio@nih.gov

  • Cancer survivorship
  • Cancer treatment toxicity and long-term health of cancer survivors
  • Patient reported outcomes
  • Health disparities
  • Medication adherence
  • Women's health
CTEB

Hoover, Elise, M.P.H.
Cancer Research Training Award Fellow

Phone: (240) 276-5768
Email: hooverem@mail.nih.gov

  • Chronic disease epidemiology
  • Women's health
  • Cancer survivorship
  • Public health policy
CTEB

Marcus, Pam, Ph.D.
Program Director

Phone: (240) 276-6901
Email: marcusp@mail.nih.gov

  • Cancer screening methodology
  • Cancer etiology
  • Surveillance for cancer recurrence
  • Health services research
  • Breast and lung cancer
  • Scientific mentoring and coaching
  • Scientific writing and editing
CTEB

Shelburne, Nonniekaye F., C.R.N.P., M.S., A.O.C.N.
Program Director

Phone: (240) 276-6897
Email: nshelburne@mail.nih.gov

  • Epidemiology and benefit-risk prediction models related to cancer treatment outcomes and toxicity and translation into clinical oncology practice

Return to Top